ZA924658B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA924658B
ZA924658B ZA924658A ZA924658A ZA924658B ZA 924658 B ZA924658 B ZA 924658B ZA 924658 A ZA924658 A ZA 924658A ZA 924658 A ZA924658 A ZA 924658A ZA 924658 B ZA924658 B ZA 924658B
Authority
ZA
South Africa
Prior art keywords
medicaments
Prior art date
Application number
ZA924658A
Other languages
English (en)
Inventor
Francis David King
Alberto Julio Kaumann
Laramie Mary Gaster
Rodney Christopher Young
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA924658(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA924658B publication Critical patent/ZA924658B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA924658A 1991-06-26 1992-06-24 Medicaments ZA924658B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113802A GB9113802D0 (en) 1991-06-26 1991-06-26 Medicaments
US08/167,846 US5464864A (en) 1991-06-26 1992-06-17 Use of tetrahydrocarbazone derivatives as 5HT1 receptor agonists

Publications (1)

Publication Number Publication Date
ZA924658B true ZA924658B (en) 1993-12-24

Family

ID=10697363

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924658A ZA924658B (en) 1991-06-26 1992-06-24 Medicaments

Country Status (35)

Country Link
US (2) US5464864A (fr)
EP (1) EP0591280B1 (fr)
JP (1) JP3261502B2 (fr)
KR (1) KR100251571B1 (fr)
CN (1) CN1034072C (fr)
AP (1) AP344A (fr)
AT (1) ATE170746T1 (fr)
BR (2) BR9206237A (fr)
CA (1) CA2113726C (fr)
CZ (3) CZ282327B6 (fr)
DE (2) DE69226953T2 (fr)
DK (1) DK0591280T3 (fr)
FI (1) FI103967B (fr)
GB (1) GB9113802D0 (fr)
HK (1) HK1014669A1 (fr)
HU (1) HU218907B (fr)
IE (1) IE922062A1 (fr)
IL (4) IL117105A0 (fr)
LU (1) LU90939I2 (fr)
MA (1) MA22563A1 (fr)
MX (1) MX9203444A (fr)
NL (1) NL300103I2 (fr)
NO (2) NO304774B1 (fr)
NZ (1) NZ243288A (fr)
PL (3) PL169392B1 (fr)
PT (1) PT100620B (fr)
RU (1) RU2137474C1 (fr)
SA (1) SA92130141B1 (fr)
SG (1) SG47877A1 (fr)
SI (1) SI9200125B (fr)
SK (3) SK280906B6 (fr)
TW (1) TW214544B (fr)
UA (1) UA41254C2 (fr)
WO (1) WO1993000086A1 (fr)
ZA (1) ZA924658B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5618948A (en) * 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
CA2179678A1 (fr) * 1995-06-23 1996-12-24 Michael Edward Flaugh Derives de substitution en 6 de 1,2,3,4-tetrahydro-9h-carbazole et de derives de substitution en 7 de 10h-cyclohepta¬7,6-b|indole
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
BR0312175A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
CN100378108C (zh) 2002-06-21 2008-04-02 苏文生命科学有限公司 对血清素受体具有亲和力、可用作治疗剂的新型四环芳基磺酰吲哚、其制备方法及其药物组合物
PT1567492E (pt) 2002-11-28 2013-07-22 Suven Life Sciences Ltd N-arilsulfonil-3-aminoalcoxi-indóis
EP1581492B1 (fr) 2002-11-28 2008-07-16 Suven Life Sciences Limited Indoles n-arylsulfonyl-3-substitues presentant une affinite pour le recepteur de la serotonine, methode de preparation et composition pharmaceutique contenant ces indoles
WO2004055026A1 (fr) 2002-12-18 2004-07-01 Suven Life Sciences Limited Indoles tetracycliques 3-substitues a affinite pour le recepteur de serotonine
CA2658986C (fr) * 2006-08-07 2014-11-25 Actelion Pharmaceuticals Ltd Derives de l'acide (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetique
EP2813144A1 (fr) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Compositions analgésiques comprenant un antihistaminique
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
WO2010073253A1 (fr) * 2008-12-22 2010-07-01 Natco Pharma Limited Procédé de préparation de frovatripan optiquement actif
CA2767576C (fr) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Compositions pharmaceutiques refermant un antiemetique et un analgesiqueopioide
US10098674B2 (en) 2009-10-22 2018-10-16 Nuvasive, Inc. System and method for posterior cervical fusion
US9204906B2 (en) 2009-10-22 2015-12-08 Nuvasive, Inc. Posterior cervical fusion system and techniques
WO2013016223A2 (fr) 2011-07-22 2013-01-31 The University Of Chicago Traitements de la migraine et de troubles apparentés
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions
EP2816030A1 (fr) 2013-06-20 2014-12-24 Duke Chem, S. A. Procédés de préparation de frovatriptan et ses énantiomères
GB201312768D0 (en) 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
EP3423041A4 (fr) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. Compositions pharmaceutiques
EP3766483A1 (fr) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Composition de poudre orodispersible comprenant un triptane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3959309A (en) * 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
US4172834A (en) * 1971-08-16 1979-10-30 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (fr) * 1983-01-04 1984-08-15 MERCK PATENT GmbH Dérivés de tétrahydrocarbazole

Also Published As

Publication number Publication date
NO934800L (no) 1993-12-23
AP9200403A0 (en) 1992-07-31
AU1977592A (en) 1993-01-25
GB9113802D0 (en) 1991-08-14
IL117104A (en) 1997-09-30
MA22563A1 (fr) 1992-12-31
DE10299042I1 (de) 2003-02-20
UA41254C2 (uk) 2001-09-17
IL117105A (en) 1998-01-04
NL300103I2 (nl) 2003-02-03
CA2113726C (fr) 2008-02-19
CN1069726A (zh) 1993-03-10
FI103967B1 (fi) 1999-10-29
EP0591280A1 (fr) 1994-04-13
PT100620A (pt) 1993-09-30
US5464864A (en) 1995-11-07
SI9200125A (en) 1992-12-31
PL171034B1 (en) 1997-02-28
NO304774B1 (no) 1999-02-15
DK0591280T3 (da) 1999-02-15
NL300103I1 (nl) 2002-12-02
RU2137474C1 (ru) 1999-09-20
NO2005011I2 (no) 2008-02-11
CZ282083B6 (cs) 1997-05-14
CZ150696A3 (en) 1997-06-11
IE922062A1 (en) 1992-12-30
BR1100460A (pt) 2000-07-18
CZ282061B6 (cs) 1997-05-14
BR9206237A (pt) 1995-04-11
NO2005011I1 (no) 2005-05-18
AU652842B2 (en) 1994-09-08
EP0591280B1 (fr) 1998-09-09
MX9203444A (es) 1993-12-01
SK280905B6 (sk) 2000-09-12
CN1034072C (zh) 1997-02-19
ATE170746T1 (de) 1998-09-15
NO934800D0 (no) 1993-12-23
US5637611A (en) 1997-06-10
DE10299042I2 (de) 2005-02-03
SA92130141B1 (ar) 2005-12-18
WO1993000086A1 (fr) 1993-01-07
SI9200125B (en) 2001-12-31
HUT68961A (en) 1995-08-28
PT100620B (pt) 1999-01-29
CA2113726A1 (fr) 1993-01-07
PL169392B1 (pl) 1996-07-31
CZ150596A3 (en) 1997-05-14
IL102322A (en) 1997-09-30
DE69226953T2 (de) 1999-05-12
SK280906B6 (sk) 2000-09-12
TW214544B (fr) 1993-10-11
HK1014669A1 (en) 1999-09-30
SK131993A3 (en) 1994-06-08
SK280907B6 (sk) 2000-09-12
PL169410B1 (pl) 1996-07-31
CZ282327B6 (cs) 1997-06-11
NZ243288A (en) 1994-09-27
KR100251571B1 (ko) 2000-07-01
JP3261502B2 (ja) 2002-03-04
IL117105A0 (en) 1996-06-18
FI935842A0 (fi) 1993-12-23
FI935842A (fi) 1993-12-23
IL102322A0 (en) 1993-01-14
JPH06508827A (ja) 1994-10-06
DE69226953D1 (de) 1998-10-15
HU218907B (hu) 2000-12-28
CZ286193A3 (en) 1994-07-13
SG47877A1 (en) 1998-04-17
LU90939I2 (fr) 2002-09-24
FI103967B (fi) 1999-10-29
IL117104A0 (en) 1996-06-18
AP344A (en) 1994-07-05

Similar Documents

Publication Publication Date Title
AP9200461A0 (en) Medicaments
GB9113802D0 (en) Medicaments
AP9100339A0 (en) Medicaments
IL103303A0 (en) Medicament
GB9115740D0 (en) Medicaments
GB9121463D0 (en) Medicament
GB9122051D0 (en) Medicines
GB9104650D0 (en) Medicaments
GB9108348D0 (en) Medicaments
ZA927925B (en) Medicaments
GB9113377D0 (en) Medicaments
GB9112675D0 (en) Medicaments
GB9113787D0 (en) Medicaments
GB9116687D0 (en) Medicaments
GB9117943D0 (en) Medicaments
GB9122472D0 (en) Medicaments
GB9122475D0 (en) Medicaments
GB9123597D0 (en) Medicaments
GB9126027D0 (en) Medicaments
GB9126378D0 (en) Medicaments
GB9126405D0 (en) Medicaments
GB9126444D0 (en) Medicaments
GB9113383D0 (en) Medicaments
GB9113381D0 (en) Medicaments
GB9113379D0 (en) Medicaments